Related Experiment Videos
Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney
1Department of Molecular Pathology, Fukushi-Mura Hospital, Toyohashi, Japan.
Abstract:
The immunohistochemically stained membrane cofactor protein of complement (MCP/CD46), one of the complement regulatory proteins, was up-regulated in some diseased kidney tissues. MCP in diseased kidneys was strongly concentrated along the glomerular capillary walls as well as in the mesangial regions, while MCP in normal kidneys was weakly detected in all glomerular structural cells and in the epithelial cells of tubules. Since the enhanced staining was noted in those areas where depositions of C3b/C3c occurred, ongoing complement reaction might be responsible for the up-regulation of MCP expression. MCP expression may be up-regulated by complement fragments generated during complement activation in glomerulonephritis. Furthermore, anti-MCP staining was stronger in intensity in patients with moderate to massive proteinuria, indicating that up-regulation of MCP expression could be directly correlated to the kidney damage.
Insights
Membrane cofactor protein (MCP/CD46) is increased in diseased kidneys, particularly where complement activation occurs. This upregulation correlates with kidney damage and proteinuria severity.
Area of Science:
- Immunology
- Nephrology
- Complement System Biology
Background:
- Membrane cofactor protein (MCP/CD46) is a complement regulatory protein.
- MCP plays a role in protecting host cells from complement-mediated damage.
Purpose of the Study:
- To investigate the expression and localization of MCP in diseased kidney tissues.
- To determine the relationship between MCP expression, complement activation, and kidney damage.
Main Methods:
- Immunohistochemical staining of kidney tissue for MCP.
- Analysis of MCP distribution in normal versus diseased kidneys.
- Correlation of MCP staining intensity with complement deposition (C3b/C3c) and proteinuria levels.
Main Results:
- MCP was significantly upregulated in diseased kidneys compared to normal kidneys.
- MCP expression was concentrated in glomerular capillary walls and mesangial regions in diseased kidneys.
- Enhanced MCP staining correlated with C3b/C3c deposition and was stronger in patients with moderate to massive proteinuria.
Conclusions:
- MCP expression is upregulated during complement activation in glomerulonephritis.
- MCP upregulation is associated with kidney damage and may be a response to complement-mediated injury.
- MCP expression levels may serve as a biomarker for kidney damage severity.